As per corporate shareholdings filed for Jun-2025, people matching Bvf Inc publicly holds 51 stocks with a net worth of over US$ 3.7 B.
These are shares held by Bvf Inc as per the shareholding data filed with the exchanges. The latest quarter tends to have missing data since not all companies may have reported their shareholding data till now.
| Stock Name | Holders Name | Current Price US$ | Quantity Held | Holding Percent | Change from Previous Qtr | Holding Value US$ | History | |
|---|---|---|---|---|---|---|---|---|
| POINT Biopharma Global Inc | Bvf Inc | 0.00 | 10,563,748 | 9.91% | 0.00 | - | ||
| Rain Oncology Inc | Bvf Inc | 3.85 | 3,526,729 | 9.69% | 0.00 | 13.6 M | ||
| Calliditas Therapeutics AB - ADR | Bvf Inc | 40.00 | 750,000 | 2.78% | 0.00 | 30 M | ||
| Pieris Pharmaceuticals Inc | Bvf Inc | 13.60 | 257,626 | 19.51% | 0.00 | 3.5 M | ||
| Allakos Inc | Bvf Inc | 0.33 | 16,552,417 | 18.31% | 0.00 | 5.5 M | ||
| GlycoMimetics Inc | Bvf Inc | 14.15 | 9,544,262 | 14.79% | 0.00 | 135.1 M | ||
| ImageneBio Inc. | Bvf Inc | 13.67 | 4,006,564 | 8.30% | 0.00 | 54.8 M | ||
| Third Harmonic Bio Inc | Bvf Inc | 5.38 | 2,372,933 | 5.26% | 0.00 | 12.8 M | ||
| Verve Therapeutics Inc | Bvf Inc | 11.13 | 6,904,050 | 7.73% | 0.00 | 76.8 M | ||
| Vigil Neuroscience Inc | Bvf Inc | 8.05 | 4,013,633 | 8.60% | 0.00 | 32.3 M | ||
| AC Immune SA | Bvf Inc | 2.04 | 19,822,436 | 19.70% | 0.00 | 40.4 M | ||
| Annexon Inc | Bvf Inc | 2.08 | 7,000,000 | 6.37% | -0.01 | 14.6 M | ||
| Axsome Therapeutics Inc | Bvf Inc | 121.20 | 1,690,221 | 3.39% | 0.00 | 204.9 M | ||
| Cidara Therapeutics Inc | Bvf Inc | 64.21 | 786,392 | 3.38% | -0.60 | 50.5 M | ||
| Celcuity Inc | Bvf Inc | 51.77 | 3,466,000 | 8.91% | 0.47 | 179.4 M | ||
| Cullinan Oncology Inc | Bvf Inc | 7.45 | 5,750,683 | 9.73% | 0.00 | 42.8 M | ||
| Eledon Pharmaceuticals Inc | Bvf Inc | 2.56 | 6,293,282 | 10.51% | 0.00 | 16.1 M | ||
| Essa Pharma Inc | Bvf Inc | 0.24 | 8,748,629 | 19.73% | 0.00 | 2.1 M | ||
| 4D Molecular Therapeutics Inc | Bvf Inc | 6.15 | 4,629,289 | 9.91% | 0.15 | 28.5 M | ||
| Foghorn Therapeutics Inc | Bvf Inc | 4.98 | 5,302,000 | 9.38% | 0.00 | 26.4 M | ||
| Monte Rosa Therapeutics Inc | Bvf Inc | 4.78 | 5,660,132 | 9.17% | 0.00 | 27.1 M | ||
| Structure Therapeutics Inc - ADR | Bvf Inc | 18.52 | 1,771,417 | 3.08% | 0.00 | 32.8 M | ||
| Immunocore Holdings plc - ADR | Bvf Inc | 31.86 | 1,024,288 | 2.04% | NEW | 32.6 M | ||
| Immunic Inc | Bvf Inc | 0.86 | 7,652,972 | 7.76% | -1.27 | 6.6 M | ||
| Ionis Pharmaceuticals Inc | Bvf Inc | 42.52 | 1,913,385 | 1.20% | 0.00 | 81.4 M | ||
| Kura Oncology Inc | Bvf Inc | 7.82 | 7,754,129 | 8.93% | 0.00 | 60.6 M | ||
| Kymera Therapeutics Inc | Bvf Inc | 41.08 | 5,502,710 | 7.80% | 0.48 | 226.1 M | ||
| Mirum Pharmaceuticals Inc | Bvf Inc | 73.98 | 2,761,333 | 5.52% | -0.07 | 204.3 M | ||
| MoonLake Immunotherapeutics - Ordinary Shares - Class A | Bvf Inc | 55.23 | 19,751,284 | 31.12% | 0.00 | 1.1 B | ||
| Olema Pharmaceuticals Inc | Bvf Inc | 5.49 | 5,295,893 | 7.72% | 0.00 | 29.1 M | ||
| Ovid Therapeutics Inc | Bvf Inc | 1.22 | 3,853,818 | 5.42% | 0.00 | 4.7 M | ||
| Protagonist Therapeutics Inc | Bvf Inc | 58.34 | 3,211,041 | 5.16% | 1.02 | 187.3 M | ||
| Palvella Therapeutics Inc. | Bvf Inc | 52.38 | 696,555 | 6.30% | 0.00 | 36.5 M | ||
| RAPT Therapeutics Inc | Bvf Inc | 11.38 | 1,154,692 | 6.98% | 0.00 | 13.1 M | ||
| Repare Therapeutics Inc | Bvf Inc | 1.65 | 10,333,600 | 24.05% | -0.04 | 17.1 M | ||
| Revolution Medicines Inc | Bvf Inc | 37.99 | 4,982,384 | 2.67% | 0.00 | 189.3 M | ||
| Septerna Inc. | Bvf Inc | 11.75 | 4,396,124 | 9.86% | 0.00 | 51.7 M | ||
| Tscan Therapeutics Inc | Bvf Inc | 1.80 | 5,226,074 | 9.21% | 0.57 | 9.4 M | ||
| Tenax Therapeutics Inc | Bvf Inc | 5.92 | 339,549 | 8.18% | 0.00 | 2.0 M | ||
| Tyra Biosciences Inc | Bvf Inc | 12.50 | 3,944,194 | 7.41% | -0.01 | 49.3 M | ||
| Verastem Inc | Bvf Inc | 9.08 | 3,404,425 | 5.53% | 2.12 | 30.9 M | ||
| Xencor Inc | Bvf Inc | 7.91 | 2,740,141 | 3.84% | 0.00 | 21.7 M | ||
| XOMA Corp | Bvf Inc | 32.63 | 2,590,303 | 21.47% | -3.45 | 84.5 M | ||
| Zymeworks BC Inc | Bvf Inc | 14.77 | 4,308,935 | 5.71% | 0.00 | 63.6 M | ||
| Avalo Therapeutics Inc | Bvf Inc | 9.38 | 1,028,049 | 9.49% | -0.08 | 9.6 M | ||
| Forte Biosciences Inc | Bvf Inc | 11.08 | 588,344 | 4.79% | -0.08 | 6.5 M | ||
| GH Research PLC | Bvf Inc | 13.40 | 8,827,712 | 14.23% | 0.00 | 118.3 M | ||
| Inventiva - ADR | Bvf Inc | 5.78 | 686,040 | 0.49% | 0.00 | 4.0 M | ||
| Molecular Partners AG - ADR | Bvf Inc | 3.70 | 1,353,968 | 3.67% | 0.00 | 5.0 M | ||
| NLS Pharmaceutics Ltd | Bvf Inc | 2.15 | 143,676 | 2.93% | 0.00 | 308.9 K | ||
| SAB Biotherapeutics Inc | Bvf Inc | 2.06 | 917,826 | 9.88% | 0.00 | 1.9 M | ||
| Galapagos NV - ADR | 31.50 | - | Investor holds below 1% | |||||
| CytomX Therapeutics Inc | 2.00 | - | Investor holds below 1% | |||||
| NewAmsterdam Pharma Company NV | 23.78 | - | Investor holds below 1% | |||||
| ITeos Therapeutics Inc | 10.15 | - | Investor holds below 1% |